UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Are women with gynecologic malignancies at risk for opioid misuse?

Gynecologic oncology, 2017-06, Vol.145, p.46-46

2017

Volltextzugriff (PDF)

Cervical cancer survivors have high rates of persistent opioid use at 6 months after radiation

Gynecologic oncology, 2017-06, Vol.145, p.8-8

2017

Volltextzugriff (PDF)

Effect of estrogen therapy on ovarian tumor cells treated with cisplatin

Gynecologic oncology, 2017-06, Vol.145, p.200-200

2017

Volltextzugriff (PDF)

Critical conversations in gynecologic oncology: Pilot study of communication skills training for fellows and advanced practice providers

Gynecologic oncology, 2017-06, Vol.145, p.207-207

2017

Volltextzugriff (PDF)

Validation of the 'surprise question' in gynecologic oncology: comparing physicians, advanced practice providers, and nurses

Gynecologic oncology, 2016-06, Vol.141, p.128-128

2016

Volltextzugriff (PDF)

Bevacizumab-induced hypertension in gynecological cancer: Does it resolve after completion of therapy?

Gynecologic oncology, 2016-06, Vol.141, p.144-144

2016

Volltextzugriff (PDF)

Symptom management in women with recurrent ovarian cancer: Do patients and providers agree on what symptoms are most important?

Gynecologic oncology, 2016-06, Vol.141, p.165-165

2016

Volltextzugriff (PDF)

A prospective, randomized, open-blinded endpoint (PROBE) trial for safety of oral apixaban vs subcutaneous enoxaparin for thromboprophylaxis in women with a suspected gynecologic malignancy

Gynecologic oncology, 2017-06, Vol.145, p.55-56

2017

Volltextzugriff (PDF)

A multiinstitutional, prospective randomized open-blinded end-point trial for safety of oral apixaban versus subcutaneous enoxaparin for thromboprophylaxis in women with suspected gynecologic malignancy

Gynecologic oncology, 2017-06, Vol.145, p.221-221

2017

Volltextzugriff (PDF)

'Ask me, do you want to know the big picture?' Gynecologic oncology patient and provider perspectives on discussing prognosis

Gynecologic oncology, 2016-06, Vol.141, p.130-130

2016

Volltextzugriff (PDF)

Non-surgical patients with advanced gynecologic cancer discharged to subacute rehabilitation centers have poor prognosis and low rates of subsequent chemotherapy

Gynecologic oncology, 2018-06, Vol.149, p.215-216

2018

Volltextzugriff (PDF)

Implementation of clinical triggers for palliative care consultation on a gynecologic oncology inpatient service: A pilot study

Gynecologic oncology, 2014-11, Vol.135 (2), p.389-390

2014

Volltextzugriff (PDF)

Needs assessment of palliative care education in gynecologic oncology fellowship: We're not teaching what we think is most important

Gynecologic oncology, 2014-11, Vol.135 (2), p.390-390

2014

Volltextzugriff (PDF)

Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis

American journal of clinical oncology, 2018-10, Vol.41 (10), p.927-932

2018

Volltextzugriff (PDF)

Preoperative opioid use in Gynecologic Oncology: A common comorbidity relevant to the perioperative period

Gynecologic oncology, 2019-07, Vol.154 (1), p.e1-e1

2019

Volltextzugriff (PDF)

Outpatient opioid prescribing after gynecologic oncology surgery: Need for individualization

Gynecologic oncology, 2018-06, Vol.149, p.224-225

2018

Volltextzugriff (PDF)

Phase I dose escalation clinical trial of stereotactic body radiation therapy (SBRT) for locoregional recurrences of ovarian cancer: Dose escalation and preliminary outcomes and quality of life results

Gynecologic oncology, 2020-10, Vol.159, p.150-151

2020

Volltextzugriff (PDF)

Specialty palliative care is underutilized in a phase I ovarian cancer population

Gynecologic oncology, 2020-10, Vol.159, p.310-311

2020

Volltextzugriff (PDF)

790P Uniform prospective molecular analysis of endometrial carcinoma: Feasibility, outcomes, and effect on management

Annals of oncology, 2023-10, Vol.34, p.S531-S531

2023

Volltextzugriff (PDF)

Patient self-reporting as a low-intensity intervention for symptom management in ovarian cancer: An exploratory analysis of GOG-259

Gynecologic oncology, 2019-07, Vol.154 (1), p.e4-e4

2019

Volltextzugriff (PDF)

Specialty Palliative Care Rotation Improves Gynecologic Oncology Fellows’ Knowledge, Rates of Explicit Teaching and Perceived Competence in Palliative Care

Gynecologic oncology, 2017-10, Vol.147 (1), p.212-212

2017

Volltextzugriff (PDF)

Phase I Dose Escalation Clinical Trial of Stereotactic Body Radiation Therapy (SBRT) for Limited Locoregional Recurrences of Ovarian Cancer

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S19-S19

2021

Volltextzugriff (PDF)

15 Oral apixaban compared to subcutaneous enoxaparin for thromboprophylaxis in women undergoing surgery for suspected gynecologic cancer: final results of a multi-institutional randomized, controlled trial

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A9-A9

2019

Volltextzugriff (PDF)

Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients

Gynecologic oncology, 2015-04, Vol.137, p.195-196

2015

Volltextzugriff (PDF)

Clinical triggers for inpatient palliative care consultation in gynecologic oncology: A needs assessment

Gynecologic oncology, 2014-06, Vol.133, p.53-53

2014

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Are women with gynecologic malignancies at risk for opioid misuse?

Cervical cancer survivors have high rates of persistent opioid use at 6 months after radiation

Effect of estrogen therapy on ovarian tumor cells treated with cisplatin

Critical conversations in gynecologic oncology: Pilot study of communication skills training for fellows and advanced practice providers

Validation of the 'surprise question' in gynecologic oncology: comparing physicians, advanced practice providers, and nurses

Bevacizumab-induced hypertension in gynecological cancer: Does it resolve after completion of therapy?

Symptom management in women with recurrent ovarian cancer: Do patients and providers agree on what symptoms are most important?

A prospective, randomized, open-blinded endpoint (PROBE) trial for safety of oral apixaban vs subcutaneous enoxaparin for thromboprophylaxis in women with a suspected gynecologic malignancy

A multiinstitutional, prospective randomized open-blinded end-point trial for safety of oral apixaban versus subcutaneous enoxaparin for thromboprophylaxis in women with suspected gynecologic malignancy

'Ask me, do you want to know the big picture?' Gynecologic oncology patient and provider perspectives on discussing prognosis

Non-surgical patients with advanced gynecologic cancer discharged to subacute rehabilitation centers have poor prognosis and low rates of subsequent chemotherapy

Implementation of clinical triggers for palliative care consultation on a gynecologic oncology inpatient service: A pilot study

Needs assessment of palliative care education in gynecologic oncology fellowship: We're not teaching what we think is most important

Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis

Preoperative opioid use in Gynecologic Oncology: A common comorbidity relevant to the perioperative period

Outpatient opioid prescribing after gynecologic oncology surgery: Need for individualization

Phase I dose escalation clinical trial of stereotactic body radiation therapy (SBRT) for locoregional recurrences of ovarian cancer: Dose escalation and preliminary outcomes and quality of life results

Specialty palliative care is underutilized in a phase I ovarian cancer population

790P Uniform prospective molecular analysis of endometrial carcinoma: Feasibility, outcomes, and effect on management

Patient self-reporting as a low-intensity intervention for symptom management in ovarian cancer: An exploratory analysis of GOG-259

Specialty Palliative Care Rotation Improves Gynecologic Oncology Fellows’ Knowledge, Rates of Explicit Teaching and Perceived Competence in Palliative Care

Phase I Dose Escalation Clinical Trial of Stereotactic Body Radiation Therapy (SBRT) for Limited Locoregional Recurrences of Ovarian Cancer

15 Oral apixaban compared to subcutaneous enoxaparin for thromboprophylaxis in women undergoing surgery for suspected gynecologic cancer: final results of a multi-institutional randomized, controlled trial

Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients

Clinical triggers for inpatient palliative care consultation in gynecologic oncology: A needs assessment

Suchergebnisse filtern